Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 3/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 9/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
| ▸ | CTSB | P07858 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7184617 | 1.00 | DPP4 (0.39) | DPP4ABCG2CYP1A1CYP1B1PTPN1 | |
| SCHEMBL7190903 | 0.92 | PTPN1 (0.41) | DPP4ABCG2CYP1A1CYP1B1PTPN1 | |
| SCHEMBL7190901 | 0.92 | PTPN1 (0.41) | DPP4ABCG2CYP1A1CYP1B1PTPN1 | |
| SCHEMBL7185036 | 0.90 | ABCG2 (0.49) | DPP4ABCG2CYP1A1CYP1B1PTPN1 | |
| SCHEMBL7185032 | 0.90 | ABCG2 (0.49) | DPP4ABCG2CYP1A1CYP1B1PTPN1 | |
| SCHEMBL7186541 | 0.89 | CTSL (0.43) | DPP4ABCG2CYP1A1CYP1B1PTPN1 | |
| SCHEMBL7186544 | 0.89 | CTSL (0.43) | DPP4ABCG2CYP1A1CYP1B1PTPN1 | |
| SCHEMBL7190102 | 0.88 | PTPN1 (0.44) | ABCG2PTPN1CTSLCTSB | |
| SCHEMBL7190096 | 0.88 | PTPN1 (0.44) | ABCG2PTPN1CTSLCTSB | |
| SCHEMBL7192240 | 0.88 | PTPN1 (0.47) | DPP4PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6603046-B1 | The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. | LICA PHARMACEUTICALS A/S (DK) | 2003-08-05 | — | — | US | disclosed |
| EP-0634927-B1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | LICA PHARMACEUTICALS AS (DK) | 2001-07-04 | — | — | EP | disclosed |